Trending
Dr. Renise De Armas (née Baptiste) has reached the pinnacle of her academic journey, earning her Doctorate in Health Administration from National University. The daughter of Margaret Roudette Baptiste of Coulibistrie and Thomas Baptiste Jr. of Harlem, Newtown, Renise comes from a family deeply rooted in public service, including her uncle, His Lordship The Hon. Justice Davidson Baptiste, and her late aunt, former Chief Magistrate and Director of Public Prosecutions Evelina Baptiste.
Dr. De Armas earned her Associate of Science degree in Biology and Psychology from Dominica State College, a Bachelor of Science in Forensic Science with a concentration in Molecular Biology from John Jay College of Criminal Justice, a Master of Science in Public Health with a concentration in Preventive Medicine, from Southern New Hampshire University, and most recently, her Doctor of Health Administration from National University.
Throughout her career, Dr. De Armas has contributed to some of the most innovative areas of modern medicine, by aligning scientific precision with the operational and regulatory demands of global healthcare. At The Rockefeller University, she supported the design of HIV broadly neutralizing vaccine therapies under the renowned Dr. Michel Nussenzweig. She later joined the Cell Therapy and Cell Engineering Facility at the Memorial Sloan Kettering Cancer Center participating in groundbreaking cancer research under globally awarded CAR-T Cell pioneers Dr. Michel Sadelain and Dr. Isabelle Rivière.
During her tenure there , she ensured that the genetically engineered immune-cell therapies manufactured by her laboratory met rigorous FDA and clinical safety standards. She even co-authored published validation studies on molecular assays used to monitor these therapies in cancer patients.
Most recently, Dr. De Armas played a strategic leadership role at a biotech startup, developing the Quality systems needed to manufacture clinical drug products for cancer therapies. Her work verified that these immunotherapies met all safety and regulatory standards before entering the commercial pharmaceutical market and ultimately reaching patients.
In recognition of her academic excellence, leadership, and professional impact, Dr. De Armas was selected as part of National University’s prestigious President’s Circle and was also inducted into multiple honor societies, including the National Society of Leadership and Success (NSLS) and Omega Nu Lambda Honor Society. Her doctoral research focused on strengthening Quality Risk Management systems within the biotech industry to improve patient safety, drug product quality, and clinical supply chain logistics.
Beyond the lab, Dr. De Armas is a devoted wife and mother. In one of the most defining moments of her journey, she successfully defended her doctoral dissertation at nine months pregnant and welcomed her son just one week later, a deeply personal testament to her resilience, discipline, and unwavering determination.
Dr. Renise De Armas (née Baptiste) has reached the pinnacle of her academic journey, earning her Doctorate in Health Administration from National University. The daughter of Margaret Roudette Baptiste of Coulibistrie and Thomas Baptiste Jr. of Harlem, Newtown, Renise comes from a family deeply rooted in public service, including her uncle, His Lordship The Hon. Justice Davidson Baptiste, and her late aunt, former Chief Magistrate and Director of Public Prosecutions Evelina Baptiste.
Dr. De Armas earned her Associate of Science degree in Biology and Psychology from Dominica State College, a Bachelor of Science in Forensic Science with a concentration in Molecular Biology from John Jay College of Criminal Justice, a Master of Science in Public Health with a concentration in Preventive Medicine, from Southern New Hampshire University, and most recently, her Doctor of Health Administration from National University.
Throughout her career, Dr. De Armas has contributed to some of the most innovative areas of modern medicine, by aligning scientific precision with the operational and regulatory demands of global healthcare. At The Rockefeller University, she supported the design of HIV broadly neutralizing vaccine therapies under the renowned Dr. Michel Nussenzweig. She later joined the Cell Therapy and Cell Engineering Facility at the Memorial Sloan Kettering Cancer Center participating in groundbreaking cancer research under globally awarded CAR-T Cell pioneers Dr. Michel Sadelain and Dr. Isabelle Rivière.
During her tenure there , she ensured that the genetically engineered immune-cell therapies manufactured by her laboratory met rigorous FDA and clinical safety standards. She even co-authored published validation studies on molecular assays used to monitor these therapies in cancer patients.
Most recently, Dr. De Armas played a strategic leadership role at a biotech startup, developing the Quality systems needed to manufacture clinical drug products for cancer therapies. Her work verified that these immunotherapies met all safety and regulatory standards before entering the commercial pharmaceutical market and ultimately reaching patients.
In recognition of her academic excellence, leadership, and professional impact, Dr. De Armas was selected as part of National University’s prestigious President’s Circle and was also inducted into multiple honor societies, including the National Society of Leadership and Success (NSLS) and Omega Nu Lambda Honor Society. Her doctoral research focused on strengthening Quality Risk Management systems within the biotech industry to improve patient safety, drug product quality, and clinical supply chain logistics.
Beyond the lab, Dr. De Armas is a devoted wife and mother. In one of the most defining moments of her journey, she successfully defended her doctoral dissertation at nine months pregnant and welcomed her son just one week later, a deeply personal testament to her resilience, discipline, and unwavering determination.
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using ‘Content here, content here’, making it look like readable English. Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for ‘lorem ipsum’ will uncover many web sites still in their infancy.
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using ‘Content here, content here’, making it look like readable English. Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for ‘lorem ipsum’ will uncover many web sites still in their infancy.
The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using ‘Content here, content here’, making
The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using ‘Content here, content here’, making it look like readable English. Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for ‘lorem ipsum’ will uncover many web sites still in their infancy.
We’re excited to introduce Emonew, Dominica’s fresh new source for general country news. From community updates to national stories, we’re here to keep you informed, connected, and up to date.
Copyright Emonews 2025
